<DOC>
	<DOCNO>NCT00972283</DOCNO>
	<brief_summary>This trial conduct Africa , Asia , Europe , United States America ( USA ) . The aim clinical trial compare NN1250 ( insulin degludec ( IDeg ) ) insulin glargine ( IGlar ) plus insulin aspart ( IAsp ) with/without metformin with/without pioglitazone subject type 2 diabetes ( main period ) follow investigate long-term safety term compare NN1250 insulin glargine plus insulin aspart without metformin without pioglitazone subject type 2 diabetes . All oral anti-diabetic drug ( OAD ) treatment discontinue , applicable , trial participant enters trial ( NN1250-3582 ) exception metformin pioglitazone . Subjects consent participate extension trial ( NN1250-3667 ) continue receive treatment randomly allocate 52 week trial NN1250-3582 . The main period register internally Novo Nordisk NN1250-3582 extension period register NN1250-3667 .</brief_summary>
	<brief_title>Comparison NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin With/Without Pioglitazone Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>For MAIN period ( NN12503582 ) : Type 2 diabetes mellitus least 6 month Ongoing daily treatment insulin ( premix , selfmix , basal , basal bolus ) least 3 month with/without oral antidiabetic drug ( OAD ) prior trial start HbA1c 7.010.0 % ( inclusive ) Body Mass Index ( BMI ) equal 40.0 kg/m^2 For EXTENSION period ( NN12503667 ) : Completion 52 week treatment period NN12503582 For MAIN period ( NN12503582 ) : Treatment insulin regimen premix , selfmix , basal , basal bolus within 3 month Cardiovascular disease within last 6 month Uncontrolled treated/untreated severe hypertension Pregnancy , breastfeeding , intention become pregnant use adequate contraceptive measure Cancer medical history cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>